Showing results (11-20 of 149) with videos related to

Sort By:
Pageof 15
Ebiomedicine|October 2, 2015
Gene Signatures Stratify Computed Tomography Screening Detected Lung Cancer in High-Risk PopulationsJiangting Hu, Mattia Boeri, Gabriella Sozzi, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 30, 2025
Upfront blood microRNA test in LDCT-reluctant individuals: insights from the biomild trialGabriella Sozzi, Federica Sabia, Luigi Rolli, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|March 24, 2017
Inflammatory status and lung function predict mortality in lung cancer screening participantsUgo Pastorino, Daniele Morelli, Alfonso Marchianò, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 9, 2011
MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancerMattia Boeri, Carla Verri, Davide Conte, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 16, 2022
Development of a Molecular Blood-Based Immune Signature Classifier as Biomarker for Risks Assessment in Lung Cancer ScreeningOrazio Fortunato, Veronica Huber, Miriam Segale, et al.
European Journal of Cancer (Oxford, England : 1990)|May 5, 2017
Baseline and postoperative C-reactive protein levels predict mortality in operable lung cancerUgo Pastorino, Daniele Morelli, Giovanni Leuzzi, et al.
Frontiers in Oncology|August 5, 2022
A Cross-Comparison of High-Throughput Platforms for Circulating MicroRNA Quantification, Agreement in Risk Classification, and Biomarker Discovery in Non-Small Cell Lung CancerChiara Gargiuli, Loris De Cecco, Andrea Mariancini, et al.
Oncotarget|November 1, 2019
Correction: Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screeningStefano Sestini, Mattia Boeri, Alfonso Marchiano, et al.
Oncotarget|October 10, 2015
Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screeningStefano Sestini, Mattia Boeri, Alfonso Marchiano, et al.
Annals of Surgical Oncology|January 5, 2019
Baseline and Postoperative C-reactive Protein Levels Predict Long-Term Survival After Lung MetastasectomyUgo Pastorino, Daniele Morelli, Giovanni Leuzzi, et al.
Pageof 15